Dutch Entertainment Stock News

On October 31, 2025, Fugro was removed from the Euronext 150 Index, coinciding with the release of its Q3 2025 sales and trading statement call. Index removals often impact trading volumes and stock demand, as index-tracking funds must adjust their portfolios to reflect constituent changes. Given the influence of index removals on institutional trading, we’ll explore how this development may shape Fugro’s broader investment narrative. AI is about to change healthcare. These 32 stocks are...

It's been a good week for Aperam S.A. ( AMS:APAM ) shareholders, because the company has just released its latest...

Koninklijke Philips N.V.'s ( AMS:PHIA ) recent earnings report didn't offer any surprises, with the shares unchanged...

Eurocommercial Properties N.V. has reported its earnings for the nine months ended September 30, 2025, with sales of €170.56 million and revenue of €203.31 million, both higher than the previous year, but with net income dropping to €74.53 million from €93.6 million a year ago. This performance highlights a situation where top-line growth did not translate into higher net profits, as both basic and diluted earnings per share from continuing operations also saw a decrease year-on-year. To...

Exor N.V. was recently added to the Euronext 100 Index and completed the settlement of a €600 million debt offering with a 3.75% annual coupon, due in 2035 and listed on the Luxembourg Stock Exchange. Index inclusion can influence trading activity as investment funds tracking the Euronext 100 may increase their holdings of Exor. We'll examine how Exor’s index addition shapes its investment narrative, particularly regarding visibility among institutional investors. Uncover the next big thing...

Shareholders might have noticed that InPost S.A. ( AMS:INPST ) filed its third-quarter result this time last week. The...

European markets have recently experienced a pullback, with the pan-European STOXX Europe 600 Index ending lower amid concerns about overvaluation in artificial intelligence-related stocks. In this context, investors often seek out opportunities that offer potential growth without excessive risk. Penny stocks, though an older term, remain relevant as they represent smaller or newer companies that can provide value and growth potential. By focusing on those with strong financials and solid...

InPost (ENXTAM:INPST) released its third quarter earnings and reported sales growth to PLN 3,768.9 million. Net income dipped to PLN 170.7 million compared to the same period last year. See our latest analysis for InPost. After reporting strong revenue growth but sliding net income, InPost’s share price momentum has continued to cool off. The stock currently trades at €10.05, with a year-to-date share price return of -39.78%. Over the past twelve months, total shareholder return stands at...

On November 6, 2025, Pharming Group N.V. reported strong quarterly earnings with nine-month sales of US$269.6 million, up from US$204.53 million the previous year, and raised its full-year 2025 revenue guidance to between US$365 million and US$375 million. A key development was the company's announcement that the FDA granted priority review for leniolisib's potential pediatric label expansion, signaling further growth opportunities for its rare disease portfolio. With robust revenue momentum...

Ever wondered if Prosus could be your next smart investment? Let’s pull back the curtain on its true value and see if the current price stacks up to reality. After a standout year with gains of 53.9%, Prosus’ shares have seen some recent volatility, dipping 1.6% in the past week and 5.5% over the past month. However, they remain up an impressive 52.7% year-to-date. Behind these moves, market watchers are eyeing news like Prosus’s continued tech investments and portfolio reshuffling, as well...

Coca-Cola Europacific Partners PLC ( AMS:CCEP ) has announced that it will be increasing its periodic dividend on the...

With a price-to-earnings (or "P/E") ratio of 18.8x Aalberts N.V. ( AMS:AALB ) may be sending bearish signals at the...

AMG Critical Materials (ENXTAM:AMG) posted a strong set of headline numbers, with earnings forecast to grow 39.9% per year, well ahead of the Dutch market’s 11.2% growth rate. Revenue, meanwhile, is expected to rise 4.7% annually, trailing the broader market’s 7.8%. The company has recently returned to profitability and has grown earnings by 7.4% per year over the past five years.

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Koninklijke Philips (ENXTAM:PHIA) just reported that its revenue is forecast to grow at 4.2% per year, trailing behind the broader Dutch market’s expected 7.8% yearly pace. After averaging a sharp 34.8% annual earnings decline over the last five years, the company has flipped back to profitability this year, though a one-off loss of €446 million in the past 12 months put a notable dent in recent results. Now, analysts are betting on earnings to jump by 35.19% per year, with profit growth set...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Heineken (ENXTAM:HEIA) shares have shown modest movement over the past month, trading at around €68.44. Investors are weighing recent performance alongside the company’s solid annual revenue and net income growth as the outlook for the beverage sector evolves. See our latest analysis for Heineken. Heineken’s 1-month share price return of 3.7% hints at improved sentiment as investors look past a tough 12 months, where the total shareholder return is still down 5.2%. Momentum appears to be...

DSM-Firmenich (ENXTAM:DSFIR) is set to present at the upcoming Partnership Opportunities in Drug Delivery (PODD) conference in Boston. Investors are watching closely, interested in potential updates on innovative drug delivery technologies. See our latest analysis for DSM-Firmenich. DSM-Firmenich’s scheduled appearance at PODD comes after a tough run for investors, with the 1-year total shareholder return sliding 33.9%. Recent momentum has faded, and shares sit at €69.8, reflecting a 28%...

Wondering whether Adyen’s current stock price offers real value, or if you could be overpaying? You’re definitely not alone in that curiosity. In the past year, Adyen’s stock has edged up only 3.0%, and it has hardly moved this month. This hints at shifting investor sentiment and new questions around growth and risk. Headlines have focused on Adyen’s continued expansion into new markets and partnerships with major retailers. This has sparked fresh debate around the future of digital payments...

Koninklijke Ahold Delhaize's (AMS:AD) stock is up by 3.5% over the past month. We wonder if and what role the company's...

Wondering if JDE Peet's stock is a great deal right now? You are not alone, especially as more investors are eyeing its recent moves. This year, the stock has surged an impressive 89%, and it is up 64.7% over the past 12 months, suggesting the market may be rethinking its growth and risk profile. Recent headlines have highlighted JDE Peet’s push to expand its global coffee presence and efforts to strengthen its sustainability commitments. Both developments have captured investor interest and...

Universal Music Group (ENXTAM:UMG) and AI music startup Udio have settled a copyright dispute and are teaming up to create a new AI-powered music platform in 2026. This collaboration signals a shift for UMG toward integrating advanced technology solutions in music creation. See our latest analysis for Universal Music Group. Following the news of Universal Music Group’s AI partnership, shares have seen some volatility, with a 6.8% slide over the past month but a modest 1.2% gain in total...

Flow Traders (ENXTAM:FLOW) released its third-quarter results, falling short of market expectations as weak revenue capture and lower net trading income weighed on profits. The company also closed $275 million in new credit facilities to support future initiatives. See our latest analysis for Flow Traders. Shares in Flow Traders have struggled to build momentum lately, sliding 6.7% after the Q3 miss and now down more than 8% over the past month. While the 1-year total shareholder return is...

On October 30, 2025, DSM-Firmenich reported solid third-quarter growth, a significant increase in Adjusted EBITDA, and provided updates on its ongoing €1 billion share repurchase program and the planned exit from its Animal Nutrition & Health business, with the divestment on track to conclude in the fourth quarter. The company also revised its full-year outlook due to unfavorable foreign exchange effects and continued volatility in vitamins, reflecting the operational challenges of its...